iRhythm Technologies, Inc. has received FDA clearance for its Zio AT device, a mobile cardiac telemetry device, after design changes. The company expects a second clearance soon, which could help it narrow the competitive gap in the market. This positive news has boosted IRTC stock by over 20%.
Vivos Therapeutics, Inc. has secured FDA clearance for its flagship oral medical device, designed to treat moderate to severe obstructive sleep apnea (OSA) and snoring in children. This breakthrough paves the way for Vivos to expand its reach in the pediatric market and offer a non-invasive, effective alternative to traditional treatments.
3D Systems Corp (DDD) stock jumped over 6% on Tuesday after receiving FDA clearance for its innovative jetted denture solution, potentially revolutionizing denture production for dental laboratories. The company’s partnership with Glidewell, a leading dental device producer, signifies the technology’s growing impact in the industry.
Epitomee Medical Ltd. has received FDA clearance for its innovative Epitomee® Capsule, a drug-free, ingestible device designed to support weight management in adults with a BMI of 25-40. This groundbreaking technology offers a new option for individuals seeking safe and effective weight loss solutions.
Shares of Modular Medical, Inc. (MODD) surged in pre-market trading after the company announced FDA clearance for its MODD1 insulin pump. Other notable movers include Eastside Distilling, YY Group Holding, and Volato Group, while C3.ai, 180 Life Sciences, and Verint Systems experienced declines.
